array(3) { ["company_details"]=> array(13) { ["name"]=> string(24) "Idexx Laboratories, Inc." ["slug"]=> string(31) "52dfe-us-idexx-laboratories-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/adce9a3c-023b-4043-9c56-fbed7dab6f62" ["description"]=> string(1658) "10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better.  IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries. Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk. Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities." ["address_street"]=> string(10) "1 Idexx Dr" ["address_place"]=> string(9) "Westbrook" ["address_region"]=> string(5) "Maine" ["founding_date"]=> string(10) "1983-02-28" ["website_domain"]=> string(9) "idexx.com" ["website_url"]=> string(21) "https://www.idexx.com" ["industry_codes"]=> array(4) { [0]=> string(43) "General Livestock, Except Dairy and Poultry" [1]=> string(33) "Veterinary Services for Livestock" [2]=> string(27) "Pharmaceutical Preparations" [3]=> string(42) "In Vitro and In Vivo Diagnostic Substances" } ["employee_count"]=> int(710) ["article_count"]=> int(638) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(94) "Achmea Investment Management B.V. Buys 10,380 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)" ["snippet_en"]=> string(299) "Achmea Investment Management B.V. raised its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 98.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 20,957 shares of the company's stock after acquiring an" ["url"]=> string(76) "https://www.marketbeat.com/instant-alerts/nasdaq-idxx-sec-filing-2024-01-25/" ["image_url"]=> NULL ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2024-01-25" ["categories"]=> array(8) { [0]=> string(11) "Acquisition" [1]=> string(16) "Share Repurchase" [2]=> string(20) "Corporate Governance" [3]=> string(14) "Issuing Shares" [4]=> string(18) "General Investment" [5]=> string(22) "Purchasing contracting" [6]=> string(12) "Stock Market" [7]=> string(11) "Regulations" } } [1]=> array(7) { ["title_en"]=> string(85) "Machina Capital S.A.S. Purchases New Shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX)" ["snippet_en"]=> string(300) "Machina Capital S.A.S. purchased a new stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 2,705 shares of the company's stock, valued at approximately $1,183,000. A numb" ["url"]=> string(76) "https://www.marketbeat.com/instant-alerts/nasdaq-idxx-sec-filing-2024-01-21/" ["image_url"]=> NULL ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2024-01-21" ["categories"]=> array(8) { [0]=> string(11) "Acquisition" [1]=> string(16) "Share Repurchase" [2]=> string(24) "Stock Research & Ratings" [3]=> string(31) "Financial Update/Profit Warning" [4]=> string(14) "Issuing Shares" [5]=> string(18) "General Investment" [6]=> string(12) "Stock Market" [7]=> string(11) "Regulations" } } [2]=> array(7) { ["title_en"]=> string(78) "IDEXX Laboratories Insiders Sell US$4.5m Of Stock, Possibly Signalling Caution" ["snippet_en"]=> string(121) "In the last year, many IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) insiders sold a substantial stake in the company which..." ["url"]=> string(76) "https://au.news.yahoo.com/idexx-laboratories-insiders-sell-us-140027652.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/8185b2ce-3d03-42c5-a924-8874d24b31d7" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-10-07" ["categories"]=> array(2) { [0]=> string(12) "Stock Market" [1]=> string(11) "Acquisition" } } [3]=> array(7) { ["title_en"]=> string(84) "Insiders At IDEXX Laboratories Sold US$4.5m In Stock, Alluding To Potential Weakness" ["snippet_en"]=> string(117) "Over the past year, many IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) insiders sold a significant stake in the company..." ["url"]=> string(76) "https://au.news.yahoo.com/insiders-idexx-laboratories-sold-us-110026400.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/a3602dd1-3ba4-42e8-8b2e-f67cc0ee3646" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-09-06" ["categories"]=> array(3) { [0]=> string(12) "Stock Market" [1]=> string(11) "Acquisition" [2]=> string(18) "China-US Relations" } } [4]=> array(7) { ["title_en"]=> string(168) "VNRX: Highlights of Capital Markets Day (Nu.Q NETs & Nu.Q Vet); Heska being acquired by Mars (increases Nu.Q Vet distribution footprint); 13 MM share offering completed" ["snippet_en"]=> string(202) "By Steven Ralston, CFA NYSE:VNRX READ THE FULL VNRX RESEARCH REPORT Highlights of Annual Capital Markets Day On May 11, 2023, VolitionRx (NYSE:VNRX) conducted the company’s Annual Capital Markets Day." ["url"]=> string(81) "https://finance.yahoo.com/news/vnrx-highlights-capital-markets-day-100000730.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/e271c2df-80d2-481c-b8c2-6b76f63d0a4f" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-06-23" ["categories"]=> array(2) { [0]=> string(11) "Acquisition" [1]=> string(5) "Event" } } [5]=> array(7) { ["title_en"]=> string(83) "IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Purchased by Wells Fargo & Company MN" ["snippet_en"]=> string(199) "Wells Fargo & Company MN boosted its position in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Rating) by 5.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC." ["url"]=> string(120) "http://www.defenseworld.net/2023/06/10/idexx-laboratories-inc-nasdaqidxx-shares-purchased-by-wells-fargo-company-mn.html" ["image_url"]=> NULL ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2023-06-10" ["categories"]=> array(2) { [0]=> string(14) "Issuing Shares" [1]=> string(11) "Acquisition" } } [6]=> array(7) { ["title_en"]=> string(79) "Fiera Capital Corp Sells 7,301 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)" ["snippet_en"]=> string(300) "Fiera Capital Corp reduced its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Get Rating) by 8.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 81,561 shares of the company's stock after selling 7,301 shares during the quart" ["url"]=> string(76) "https://www.marketbeat.com/instant-alerts/nasdaq-idxx-sec-filing-2023-05-08/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/c3c69923-8291-4c44-b75a-96e527c1d502" ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2023-05-08" ["categories"]=> array(5) { [0]=> string(11) "Acquisition" [1]=> string(24) "Stock Research & Ratings" [2]=> string(10) "Divestment" [3]=> string(14) "Issuing Shares" [4]=> string(12) "Stock Market" } } [7]=> array(7) { ["title_en"]=> string(90) "Retirement Systems of Alabama Sells 1,120 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)" ["snippet_en"]=> string(236) "Retirement Systems of Alabama trimmed its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Rating) by 4.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission." ["url"]=> string(129) "https://www.defenseworld.net/2023/05/01/retirement-systems-of-alabama-sells-1120-shares-of-idexx-laboratories-inc-nasdaqidxx.html" ["image_url"]=> NULL ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2023-05-01" ["categories"]=> array(5) { [0]=> string(11) "Acquisition" [1]=> string(24) "Stock Research & Ratings" [2]=> string(10) "Divestment" [3]=> string(14) "Issuing Shares" [4]=> string(12) "Stock Market" } } [8]=> array(7) { ["title_en"]=> string(76) "Quent Capital LLC Sells 248 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)" ["snippet_en"]=> string(304) "Quent Capital LLC cut its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Rating) by 61.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 157 shares of the company’s stock after selling 248 shares during the quarter." ["url"]=> string(116) "https://www.defenseworld.net/2023/03/30/quent-capital-llc-sells-248-shares-of-idexx-laboratories-inc-nasdaqidxx.html" ["image_url"]=> NULL ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2023-03-30" ["categories"]=> array(4) { [0]=> string(12) "Stock Market" [1]=> string(14) "Issuing Shares" [2]=> string(11) "Acquisition" [3]=> string(10) "Divestment" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(116) } [1]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(65) } [2]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(43) } [3]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(43) } [4]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(40) } [5]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(23) } [6]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(22) } [7]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(22) } [8]=> array(2) { ["name"]=> string(12) "Restatements" ["count"]=> int(21) } [9]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(19) } [10]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(18) } [11]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(16) } [12]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(14) } [13]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(12) } [14]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(9) } [15]=> array(2) { ["name"]=> string(9) "Investors" ["count"]=> int(9) } [16]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(8) } [17]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(8) } [18]=> array(2) { ["name"]=> string(31) "Water and Wastewater Management" ["count"]=> int(7) } [19]=> array(2) { ["name"]=> string(16) "Share Repurchase" ["count"]=> int(7) } [20]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(7) } [21]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(7) } [22]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(7) } [23]=> array(2) { ["name"]=> string(13) "Credit Rating" ["count"]=> int(6) } [24]=> array(2) { ["name"]=> string(10) "New Market" ["count"]=> int(6) } [25]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(5) } [26]=> array(2) { ["name"]=> string(15) "Blogs & Columns" ["count"]=> int(5) } [27]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(5) } [28]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(5) } [29]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(5) } } } 52dfe-us-idexx-laboratories-inc